期刊文献+

肿瘤相关免疫细胞在卵巢癌中的作用及研究进展 被引量:3

下载PDF
导出
摘要 卵巢癌是女性生殖系统常见的三大恶性肿瘤之一,发病率仅次于宫颈癌和子宫内膜癌。由于卵巢在盆腔的位置较深,早期病变不易被发现,晚期病例的治疗效果不佳,卵巢癌病死率居妇科肿瘤之首。目前抗肿瘤治疗主要针对肿瘤细胞本身,但是肿瘤的发生、发展还受其周围微环境的影响。肿瘤微环境由免疫细胞和细胞外基质成分组成,免疫细胞是肿瘤微环境中的重要组成部分,其在肿瘤的发生、耐药、侵袭和转移过程中可能起着重要作用。所以,本文对肿瘤微环境中主要的免疫细胞(如巨噬细胞和调节性T细胞)在卵巢癌中的作用及研究进展进行综述,旨在为寻找新的抗肿瘤治疗方法提供线索。 Ovarian cancer is one of the three most common malignancies of the female reproductive system,and its incidence is secondary to cervical cancer and endometrial carcinoma.Because the ovary is located in the deep pelvic cavity,early lesions are not easy to be found,and advanced cases also lack effective treatment methods,the mortality rate of ovarian cancer is the highest in gynecological tumors.At present,anti-tumor therapy is mainly aimed at the tumor cells themselves,but the occurrence and development of tumors are also affected by the surrounding microenvironment.The tumor microenvironment consists of immune cells and extracellular matrix components.Immune cells are an important part of the tumor microenvironment,which may play an important role in the process of tumor occurrence,drug resistance,invasion and metastasis.Therefore,this article reviews the role and research progress of major immune cells(such as macrophages and regulatory T cells)in the tumor microenvironment of ovarian cancer,and aims to provide clues for finding new anti-tumor treatment methods.
出处 《妇产与遗传(电子版)》 2020年第4期55-59,共5页 Obstetrics-Gynecology and Genetics (Electronic Edition)
基金 国家自然科学基金青年科学基金项目(81402127) 南方医院高层次课题匹配基金项目(2014030) 广东省医学科学技术研究基金(A2018138) 南方医院院长基金(2019B019) 南方医科大学2017年度、2018年度、2020年度大学生创新创业训练计划项目(201712121133、201812121139、X202012121185) 2019年度南方医院院级教育研究课题项目(19NJ-ZDPY11)。
关键词 卵巢肿瘤 肿瘤微环境 肿瘤相关巨噬细胞 调节性T细胞 Ovarian neoplasm Tumor microenvironment Tumor associated macrophage Regulatory T cells
  • 相关文献

参考文献1

二级参考文献24

  • 1Bjormland K,Flatmark K,Pettersen S,et al.Matrix metalloproteinases participate in osteosarcoma invasion[J].J Surg Res,2005,127(2):151-156.
  • 2Lengyel E,Schmalfeldt B,Konik E,et al.Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer[J].Gynecol Oncol,2001,82(2):291-298.
  • 3Park D W,Ryu H S,Choi D S,et al.Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro[J].Gynecol Oncol,2001,82(3):442-449.
  • 4Manenti L,Paganoni P,Floriani I,ct al.Expression levels of vascular endothelial growth factor,matrix metalloproteinases2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma[J].Eur J Cancer,2003,39 (13):1948-1956.
  • 5de Vicente J C,Fresno M F,Villalain L,et al.Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma[J].Oral Oncol,2005,41(3):283-293.
  • 6Mook O R,Frederiks W M,Van Noorden C J.The role of gelatinases in colorectal cancer progression and metastasis[J].Biochim Biophys Acta,2004,1705(2):69-89
  • 7Yang C,Zeisberg M,Mosterman B,et al.Liver fibrosis:insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors[J].Gastroenterology,2003,124(1):147-159.
  • 8Szabo K A,Ablin R J,Singh G.Matrix metalloproteinases and the immune response[J].Clin Applied Immunol,2004,4(5):295-319.
  • 9Tanimura S,Asato K,Fujishiro S H,et al.Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells:down-regulation of matrix metalloproteinase-3/-9/-14 and CD44[J].Biochem Biophys Res Commun,2003,304(4):801-806.
  • 10Davidson B,Goldberg I,Reich R,et al.αV-and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients[J].Gynecol Oncol,2003,90 (2):248 -257.

共引文献12

同被引文献24

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部